1. Home
  2. ALDX vs TDUP Comparison

ALDX vs TDUP Comparison

Compare ALDX & TDUP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALDX
  • TDUP
  • Stock Information
  • Founded
  • ALDX 2004
  • TDUP 2009
  • Country
  • ALDX United States
  • TDUP United States
  • Employees
  • ALDX N/A
  • TDUP N/A
  • Industry
  • ALDX Biotechnology: Pharmaceutical Preparations
  • TDUP Catalog/Specialty Distribution
  • Sector
  • ALDX Health Care
  • TDUP Consumer Discretionary
  • Exchange
  • ALDX Nasdaq
  • TDUP Nasdaq
  • Market Cap
  • ALDX 398.3M
  • TDUP 368.3M
  • IPO Year
  • ALDX 2014
  • TDUP 2021
  • Fundamental
  • Price
  • ALDX $2.12
  • TDUP $3.48
  • Analyst Decision
  • ALDX Strong Buy
  • TDUP Buy
  • Analyst Count
  • ALDX 3
  • TDUP 5
  • Target Price
  • ALDX $9.67
  • TDUP $3.50
  • AVG Volume (30 Days)
  • ALDX 3.3M
  • TDUP 947.1K
  • Earning Date
  • ALDX 05-01-2025
  • TDUP 05-05-2025
  • Dividend Yield
  • ALDX N/A
  • TDUP N/A
  • EPS Growth
  • ALDX N/A
  • TDUP N/A
  • EPS
  • ALDX N/A
  • TDUP N/A
  • Revenue
  • ALDX N/A
  • TDUP $260,031,000.00
  • Revenue This Year
  • ALDX N/A
  • TDUP $8.43
  • Revenue Next Year
  • ALDX N/A
  • TDUP $6.58
  • P/E Ratio
  • ALDX N/A
  • TDUP N/A
  • Revenue Growth
  • ALDX N/A
  • TDUP 0.59
  • 52 Week Low
  • ALDX $1.14
  • TDUP $0.50
  • 52 Week High
  • ALDX $7.20
  • TDUP $3.54
  • Technical
  • Relative Strength Index (RSI)
  • ALDX 26.33
  • TDUP 75.34
  • Support Level
  • ALDX $1.79
  • TDUP $2.29
  • Resistance Level
  • ALDX $2.32
  • TDUP $2.61
  • Average True Range (ATR)
  • ALDX 0.49
  • TDUP 0.24
  • MACD
  • ALDX -0.32
  • TDUP 0.09
  • Stochastic Oscillator
  • ALDX 17.53
  • TDUP 95.60

About ALDX Aldeyra Therapeutics Inc.

Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.

About TDUP ThredUp Inc.

ThredUp Inc is an online resale platform for women and kids apparel, shoes, and accessories. It generates revenue from items that are sold to buyers through the website, mobile app and RaaS partners. Geographically, the majority of the company's revenue is generated from United States.

Share on Social Networks: